Agenda
(Subject to change – depending upon the geographical location of most of our delegates, we may start the virtual programme earlier or later than the times advertised below)
We have tried to group similar talks, but due to the wide geographical locations of our speakers, this may not have always been possible.
(World Time Converter: https://www.worldtimebuddy.com)
Please check your mailboxes (including spam folders) for the following:
>Password to access conference documents, &
>Codes to access online meeting
Please contact PhageOxford@gmail.com, should you have any questions.
Day 1: Tuesday 07th September
1015: Welcome and introduction
1020: Welcome by the conference chair – Professor Martha Clokie
Therapy and therapeutics-I: Chair Professor Martha Clokie
1030: Dr Aleksandra Petrovic Fabijan
Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Sydney, New South Wales, Australia
Escherichia coli L-forms: what doesn’t kill them makes them stronger
1050: Dr Gabriel De Freitas Almeida
Senior Researcher, Department of Biological and Environmental Science, University of Jyväskylä, Jyväskylän yliopisto, Finland
Mucosal interactions as a bridge between past and future prophylactic phage therapy
1110: Professor Martin Loessner
Institute of Food, Nutrition and Health, ETH Zürich, Zürich, Switzerland
Making of: Next-generation phages for diagnostics and infection therapy
1130: Professor Aidan Coffey
Department of Biological Sciences and the Centre for Research in Advanced Therapeutic Engineering (CREATE), Munster Technological University, Cork, Ireland
Bacteriophage endolysins for control of Gram positive pathogens: successes and challenges
1150: Dr Joanna Żebrowska
Department of Molecular Biotehnology, Faculty of Chemistry, University of Gdansk, Gdansk, Poland
Cloning and expression of thermostable TP-84 bacteriophage endolysin, construction of its fusion derivatives and prospective applications
Molecular biology, evolution and bioinformatics: Chair Professor Aidan Coffey
1210: Dr Kathryn Styles
The School of Life Sciences, University of Warwick, Coventry, UK
Transposon rearrangements allow for the development of resistance to K1F bacteriophage
1230: Professor Alfonso Jaramillo
The School of Life Sciences, University of Warwick, Coventry, UK
New protein function by phage-assisted continuous evolution
1250: Dr Pavel Payne
Central European Institute of Technology, Masaryk University, Brno, Czech Republic
CRISPR, herd immunity and transduction – an unexpected way of bacterial reproduction
1310: Break
1330: Dr Mohamed A Alfaleh
Vaccine and Immunotherapy Unit, King Fahd Medical Research Center, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
Selection of membrane proteins specific antibodies with diverse binding properties from a phage display library using cell-based biopanning
1350: Dr Diana Priscila Pires
CEB – Centre of Biological Engineering, University of Minho, Campus de Gualtar, Braga, Portugal
Engineering Pseudomonas aeruginosa phages with reduced genomes
1410: Professor Mathias Middelboe
Department of Biology, Marine Biological Section, University of Copenhagen, Helsingør, Denmark
Phage-driven evolution in the fish pathogen Flavobacterium psychrophilum: implications for pathogen control in aquaculture
1430: Dr Pavol Bardy
University of York, York, UK
Ecological abundance and diversity of membrane phages revealed by characterisation of a freshwater pseudolysogenic corticovirus
1450: Dr Enrique González-Tortuero
School of Science, Engineering and Environment, University of Salford, Salford, UK
Improving phage genome annotation to understand phage biology: the case of Pseudomonas aeruginosa LES prophages
1500: Break
Food and biotechnology: Chair Professor Martin Loessner
1520: Professor Jennifer Mahony
Professor of Molecular Food Microbiology, School of Microbiology & APC Microbiome, University College Cork, Cork, Ireland
Phage-host interactions in dairy streptococci
1540: Dr Hansjörg Lehnherr
PTC Phage Technology Center GmbH, Bönen, NRW, Germany
Bacteriophages for weaning piglets
1600: Dr Olivia McAuliffe
Principal Research Officer, Cultures, Fermentation and Biotransformation, Teagasc Food Research Centre, Fermoy, Cork, Ireland
Phage application against foodborne pathogens
1620: Dr Evelien Adriaenssens
Group Leader, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK
Phage taxonomy: do we really need it?
1640: Dr Hany Anany
Guelph Research and Development Centre, Agriculture and Agri-Food Canada / Government of Canada, Guelph, ON, Canada
SMART design of a Broad Host Range Multiple-receptor Phage Cocktail to tackle Salmonella in Poultry
1700: Dr Michela Gambino
Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg C, Denmark
Determinants of phage host range in porcine enterotoxigenic Escherichia coli
1720: Close of Day 1
Day 2: Wednesday 08th September
1025: Welcome
ECR Symposium-I: Dr Melissa Haines
1030: Mr Yukgehnaish Kumarasan
Faculty of Applied Sciences, AIMST University, Jalan Bedong-Semeling, Bedong, Kedah, Malaysia
PhageLeads: predicting therapeutic phage suitability
1050: Mr Sang Guen Kim
Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea
Bacteriophage emulsion, a new method for egg safety against Salmonella colonization
1110: Miss Marta Siborova
CEITEC, Masaryk University, Brno, South Moravian, Czech Republic
Conformational changes of short tail fibers enable genome delivery of Podoviridae phage SU10
1130: Miss Amira R Vitt
Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg C, Denmark
Isolation and characterization of bacteriophages for biocontrol of extended spectrum beta-lactamase – producing Escherichia coli
1150: Mr Rubén Enrique Pérez Bucio
Center for Genomic Sciences, National Autonomous University of México, Morelos México
EnVhog: Shedding light over phage protein uncertainty
1210: Dr Revathy Krishnamurthi
Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences (IVES), University of Liverpool, Liverpool, UK
Do temperate bacteriophages work together as puppet masters of their bacterial hosts?
1230: Break
ECR Symposium-II: Chair Dr Mohammed Imam
1240: Mr Alhassan Alrafaie
Integrated BioSciences, School of Clinical Dentistry, University of Sheffield, Sheffield, UK
Enterococcal Bacteriophage: A review of the Tail Associated Lysin Landscape
1300: Mr Sherif Kandil
Harper Adams University, Newport, Shropshire, UK
Bacteriophage-mediated reduction of Staphylococcus aureus in raw cow’s milk prepared for artisan cheese manufacture
1320: Mr Joshua Williams
The School of Life Sciences, University of Warwick, Gibbet Hill Road, Coventry, UK
Engineering bacteriophages as multi-tools against intracellular Escherichia coli K1 infections
1340: Mr Lei Tian
Department of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada
Nanofibrous Viral Microgels: High-Throughput Synthesis of Ordered, Detachable and Bioactive Bacteriophage Microgel Arrays
1400: Mrs Fereshteh Bayat
School of Biomedical Engineering, McMaster University, Hamilton, Ontario, Canada
Phage Treatment Removes Biofilm and Recovers Sensitivity for Biofouled Dissolved Oxygen Sensors
1420: Break
Therapy and therapeutics-II: Chair Professor Mathias Middelboe
1430: Professor Martha Clokie
Department of Infection, Immunity and Inflammation, University of Leicester, UK
Developing phage therapy with your feet on the ground and your head in the clouds
1450: Dr Sabrina Green
Director of Research & Development, TAILΦR Service Center, One Baylor Plaza, Houston, TX, USA
Developing an expedited pipeline for tailored phage therapeutics for multidrug-resistant infections
1510: Dr Luís Melo
Centre of Biological Engineering, University of Minho Braga, 4710-057 Braga, Portugal
Staphylococcus epidermidis biofilm matrix confers protection against phage predation
1530: Miss Xena Dyball
Public Health England, Manor Farm Road, Salisbury, Wiltshire, UK
Rapid characterisation of phage susceptibility using a bacterial impedance cytometer
1550: Dr Beata Łubkowska
Department of Molecular Biotehnology, Faculty of Chemistry, University of Gdansk, Gdansk, Poland
Cloning and expression of recombinant, thermostable TP-84 bacteriophage depolymerase-glicosylase as a potential tool for biofilms elimination
1610: Ramchander Rohit Kongari
United States Food and Drug Administration, Division of Bacterial, Parasitic, and Allergenic Products, Center for Biologics Evaluation and Research, Silver Spring, MD, USA
A transcriptomics-based approach to understand host-phage interactions between Staphylococcus aureusand bacteriophage K
1630: Closing remarks by the conference chair – Professor Martha Clokie
1650: Close
